Postoperative urinary dysfunction following lateral lymph node dissection for rectal cancer via minimally invasive surgery

Table 1 Patient characteristics (n = 100)

Factor	Number
Age (years old)	63 (26–83)
Sex (male/female)	72/28
BMI (kg/m²)	22.5 (17.1–33.1)
Comorbidities (yes/no)	48/40
・BPH (yes/no)*	7/57*
Prostate-related comorbidities (yes/no)**	9/55*
・Previous abdominal surgery (yes/no)	25/56
ASA (1/2/3)	23/74/0
Preoperative treatment (TNT/NACRT/NAC/none)	3/18/45/34
Tumor location (Ra/Rb)	20/80
Distance from AV to tumor (cm)	5 (0–11)
(y)pStage (0(pCR)/I/II/IIIA/IIIB/IV)	3/14/25/20/11/13

*Only males
**Prostate-related comorbidities involve BPH and prostate cancer after treatment
Abbreviations: BMI: body mass index; BPH: benign prostatic hyperplasia; ASA: American Society of Anesthesiologists Physical Status; TNT: total neoadjuvant therapy; NACRT: neoadjuvant chemoradiotherapy; NAC: neoadjuvant chemotherapy; Ra: upper rectum; Rb: lower rectum; AV: anal verge; (y)pStage: (post preoperative therapy) pathological stage; pCR: pathological complete response

ISSN: 1471-2482